Does MOMETASONE FUROATE Cause Epistaxis? 122 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Epistaxis have been filed in association with MOMETASONE FUROATE (Mometasone Furoate). This represents 1.1% of all adverse event reports for MOMETASONE FUROATE.
122
Reports of Epistaxis with MOMETASONE FUROATE
1.1%
of all MOMETASONE FUROATE reports
0
Deaths
10
Hospitalizations
How Dangerous Is Epistaxis From MOMETASONE FUROATE?
Of the 122 reports, 10 (8.2%) required hospitalization, and 2 (1.6%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
Yes, Epistaxis is listed as a known adverse reaction in the official FDA drug label for MOMETASONE FUROATE.
What Other Side Effects Does MOMETASONE FUROATE Cause?
No adverse event (3,717)
Product quality issue (3,406)
Poor quality device used (2,159)
Drug dose omission (2,005)
Dyspnoea (1,522)
Device malfunction (1,332)
Asthma (1,307)
Wheezing (1,142)
Cough (1,052)
Gastrooesophageal reflux disease (1,029)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which MOMETASONE FUROATE Alternatives Have Lower Epistaxis Risk?
MOMETASONE FUROATE vs MOMETASONE FUROATE\OLOPATADINE
MOMETASONE FUROATE vs MONOMETHYL
MOMETASONE FUROATE vs MONTELUKAST
MOMETASONE FUROATE vs MONTELUKAST\MONTELUKAST
MOMETASONE FUROATE vs MONTMORILLONITE